Biomarkers for the diagnosis of neonatal sepsis and necrotizing enterocolitis: Clinical practice guidelines

Early Human Development

Volumn 105, Issue , 2017, Pages 25-33

  Gilfillan, Margaret ^a   Bhandari, Vineet ^a  

^a ST CHRISTOPHER'S HOSPITAL FOR CHILDREN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CD64 ANTIGEN; CELL ADHESION MOLECULE; CHEMOKINE; CYTOKINE; HEPCIDIN; PROCALCITONIN; SERUM AMYLOID A;

ANTIBIOTIC THERAPY; ARTICLE; GENOMICS; HEMATOLOGICAL PARAMETERS; HUMAN; MEASUREMENT; METABOLOMICS; NECROTIZING ENTEROCOLITIS; NEUTROPHIL; NEWBORN SEPSIS; PRACTICE GUIDELINE; PROTEOMICS; BLOOD; NEWBORN;

BIOMARKERS; ENTEROCOLITIS, NECROTIZING; HUMANS; INFANT, NEWBORN; NEONATAL SEPSIS; PRACTICE GUIDELINES AS TOPIC;

EID: 85010584529     PISSN: 03783782     EISSN: 18726232     Source Type: Journal    
DOI: 10.1016/j.earlhumdev.2016.12.002     Document Type: Article

References (103)

1. [1] Stoll, B.J., Hansen, N.I., Bell, E.F., Shankaran, S., Laptook, A.R., Walsh, M.C., et al. Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics 126 (2010), 443–456.
2. [2] Polin, R.A., Newborn CoFa. Management of neonates with suspected or proven early-onset bacterial sepsis. Pediatrics 129 (2012), 1006–1015.
3. [3] Lever, A., Mackenzie, I., Sepsis: definition, epidemiology, and diagnosis. BMJ 335 (2007), 879–883.
4. [4] Ohlsson A, Shah VS. Intrapartum antibiotics for known maternal Group B streptococcal colonization. Cochrane Database Syst. Rev. 2014:CD007467.
5. [5] Stoll, B.J., Hansen, N.I., Sánchez, P.J., Faix, R.G., Poindexter, B.B., Van Meurs, K.P., et al. Early onset neonatal sepsis: the burden of group B Streptococcal and E. coli disease continues. Pediatrics 127 (2011), 817–826.
6. [6] Neu, J., Preterm infant nutrition, gut bacteria, and necrotizing enterocolitis. Curr. Opin. Clin. Nutr. Metab. Care 18 (2015), 285–288.
7. [7] Luig, M., Lui, K., Group NAN, Epidemiology of necrotizing enterocolitis–part II: risks and susceptibility of premature infants during the surfactant era: a regional study. J. Paediatr. Child Health 41 (2005), 174–179.
8. [8] Bassler, D., Stoll, B.J., Schmidt, B., Asztalos, E.V., Roberts, R.S., Robertson, C.M., et al. Using a count of neonatal morbidities to predict poor outcome in extremely low birth weight infants: added role of neonatal infection. Pediatrics 123 (2009), 313–318.
9. [9] Haller, S., Deindl, P., Cassini, A., Suetens, C., Zingg, W., Abu Sin, M., et al. Neurological sequelae of healthcare-associated sepsis in very-low-birthweight infants: umbrella review and evidence-based outcome tree. Euro Surveill., 21, 2016.
10. [10] Hintz, S.R., Kendrick, D.E., Stoll, B.J., Vohr, B.R., Fanaroff, A.A., Donovan, E.F., et al. Neurodevelopmental and growth outcomes of extremely low birth weight infants after necrotizing enterocolitis. Pediatrics 115 (2005), 696–703.
11. [11] Butin, M., Rasigade, J.P., Martins-Simões, P., Meugnier, H., Lemriss, H., Goering, R.V., et al. Wide geographical dissemination of the multiresistant Staphylococcus capitis NRCS-A clone in neonatal intensive-care units. Clin. Microbiol. Infect. 22 (2016), 46–52.
12. [12] Tzialla, C., Borghesi, A., Pozzi, M., Stronati, M., Neonatal infections due to multi-resistant strains: epidemiology, current treatment, emerging therapeutic approaches and prevention. Clin. Chim. Acta 451 (2015), 71–77.
13. [13] Ottolini, M.C., Lundgren, K., Mirkinson, L.J., Cason, S., Ottolini, M.G., Utility of complete blood count and blood culture screening to diagnose neonatal sepsis in the asymptomatic at risk newborn. Pediatr. Infect. Dis. J. 22 (2003), 430–434.
14. [14] Gonzalez, B.E., Mercado, C.K., Johnson, L., Brodsky, N.L., Bhandari, V., Early markers of late-onset sepsis in premature neonates: clinical, hematological and cytokine profile. J. Perinat. Med. 31 (2003), 60–68.
15. [15] Bell, M.J., Ternberg, J.L., Feigin, R.D., Keating, J.P., Marshall, R., Barton, L., et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann. Surg. 187 (1978), 1–7.
16. [16] Walsh, M.C., Kliegman, R.M., Necrotizing enterocolitis: treatment based on staging criteria. Pediatr. Clin. N. Am. 33 (1986), 179–201.
17. [17] Bhandari, V., Effective biomarkers for diagnosis of neonatal sepsis. J. Pediatr. Infect. Dis. Soc. 3 (2014), 234–245.
18. [18] Mally, P., Xu, J., Hendricks-Munoz, K.D., Biomarkers for neonatal sepsis: recent developments. Res. Rep. Neonatol.: Dovepress, 2014, 157–168.
19. [19] Chiesa, C., Panero, A., Osborn, J.F., Simonetti, A.F., Pacifico, L., Diagnosis of neonatal sepsis: a clinical and laboratory challenge. Clin. Chem. 50 (2004), 279–287.
20. [20] Newman, T.B., Puopolo, K.M., Wi, S., Draper, D., Escobar, G.J., Interpreting complete blood counts soon after birth in newborns at risk for sepsis. Pediatrics 126 (2010), 903–909.
21. [21] Hornik, C.P., Benjamin, D.K., Becker, K.C., Li, J., Clark, R.H., Cohen-Wolkowiez, M., et al. Use of the complete blood cell count in late-onset neonatal sepsis. Pediatr. Infect. Dis. J. 31 (2012), 803–807.
22. [22] Makkar, M., Gupta, C., Pathak, R., Garg, S., Mahajan, N.C., Performance evaluation of hematologic scoring system in early diagnosis of neonatal sepsis. J. Clin. Neonatol. 2 (2013), 25–29.
23. [23] Wang K, Bhandari V, Chepustanova S, Huber G, O'Hara S, O'Hern CS, et al. Which biomarkers reveal neonatal sepsis? PLoS One 2013;8:e82700.
24. [24] Streimish, I., Bizzarro, M., Northrup, V., Wang, C., Renna, S., Koval, N., et al. Neutrophil CD64 with hematologic criteria for diagnosis of neonatal sepsis. Am. J. Perinatol. 31 (2014), 21–30.
25. [25] Çelik, H.T., Portakal, O., Yiğit, Ş., Hasçelik, G., Korkmaz, A., Yurdakök, M., Efficacy of new leukocyte parameters versus serum C-reactive protein, procalcitonin, and interleukin-6 in the diagnosis of neonatal sepsis. Pediatr. Int. 58 (2016), 119–125.
26. [26] Gordon, P.V., Swanson, J.R., Clark, R., Spitzer, A., The complete blood cell count in a refined cohort of preterm NEC: the importance of gestational age and day of diagnosis when using the CBC to estimate mortality. J. Perinatol. 36 (2016), 121–125.
27. [27] Janeway, C.A., Medzhitov, R., Innate immune recognition. Annu. Rev. Immunol. 20 (2002), 197–216.
28. [28] Mishra, U.K., Jacobs, S.E., Doyle, L.W., Garland, S.M., Newer approaches to the diagnosis of early onset neonatal sepsis. Arch. Dis. Child. Fetal Neonatal Ed. 91 (2006), F208–F212.
29. [29] Ng, P.C., Cheng, S.H., Chui, K.M., Fok, T.F., Wong, M.Y., Wong, W., et al. Diagnosis of late onset neonatal sepsis with cytokines, adhesion molecule, and C-reactive protein in preterm very low birthweight infants. Arch. Dis. Child. Fetal Neonatal Ed. 77 (1997), F221–F227.
30. [30] Ng, P.C., Li, K., Wong, R.P., Chui, K., Wong, E., Li, G., et al. Proinflammatory and anti-inflammatory cytokine responses in preterm infants with systemic infections. Arch. Dis. Child. Fetal Neonatal Ed. 88 (2003), F209–F213.
31. [31] Chiesa, C., Pacifico, L., Natale, F., Hofer, N., Osborn, J.F., Resch, B., Fetal and early neonatal interleukin-6 response. Cytokine 76 (2015), 1–12.
32. [32] Ganesan, P., Shanmugam, P., Sattar, S.B., Shankar, S.L., Evaluation of IL-6, CRP and hs-CRP as early markers of neonatal sepsis. J. Clin. Diagn. Res. 10 (2016), DC13–DC17.
33. [33] Shahkar, L., Keshtkar, A., Mirfazeli, A., Ahani, A., Roshandel, G., The role of IL-6 for predicting neonatal sepsis: a systematic review and meta-analysis. Iran. J. Pediatr. 21 (2011), 411–417.
34. [34] Delanghe, J.R., Speeckaert, M.M., Translational research and biomarkers in neonatal sepsis. Clin. Chim. Acta 451 (2015), 46–64.
35. [35] Hofer, N., Edlinger, S., Resch, B., Comparison of risk for early-onset sepsis in small-for-gestational-age neonates and appropriate-for-gestational-age neonates based on lower levels of white blood cell, neutrophil, and platelet counts. Pediatr. Neonatol. 55 (2014), 323–325.
36. [36] Hofer, N., Zacharias, E., Müller, W., Resch, B., An update on the use of C-reactive protein in early-onset neonatal sepsis: current insights and new tasks. Neonatology 102 (2012), 25–36.
37. [37] Celik, I.H., Demirel, F.G., Uras, N., Oguz, S.S., Erdeve, O., Biyikli, Z., et al. What are the cut-off levels for IL-6 and CRP in neonatal sepsis?. J. Clin. Lab. Anal. 24 (2010), 407–412.
38. [38] Bender, L., Thaarup, J., Varming, K., Krarup, H., Ellermann-Eriksen, S., Ebbesen, F., Early and late markers for the detection of early-onset neonatal sepsis. Dan. Med. Bull. 55 (2008), 219–223.
39. [39] Ng, P.C., Li, K., Leung, T.F., Wong, R.P., Li, G., Chui, K.M., et al. Early prediction of sepsis-induced disseminated intravascular coagulation with interleukin-10, interleukin-6, and RANTES in preterm infants. Clin. Chem. 52 (2006), 1181–1189.
40. [40] Choo, Y.K., Cho, H.S., Seo, I.B., Lee, H.S., Comparison of the accuracy of neutrophil CD64 and C-reactive protein as a single test for the early detection of neonatal sepsis. Korean J. Pediatr. 55 (2012), 11–17.
41. [41] Shi, J., Tang, J., Chen, D., Meta-analysis of diagnostic accuracy of neutrophil CD64 for neonatal sepsis. Ital. J. Pediatr., 42(57), 2016.
42. [42] Lam, H.S., Wong, S.P., Cheung, H.M., Chu, W.C., Wong, R.P., Chui, K.M., et al. Early diagnosis of intra-abdominal inflammation and sepsis by neutrophil CD64 expression in newborns. Neonatology. 99 (2011), 118–124.
43. [43] Bleharski, J.R., Kiessler, V., Buonsanti, C., Sieling, P.A., Stenger, S., Colonna, M., et al. A role for triggering receptor expressed on myeloid cells-1 in host defense during the early-induced and adaptive phases of the immune response. J. Immunol. 170 (2003), 3812–3818.
44. [44] Adly AA, Ismail EA, Andrawes NG, El-Saadany MA. Circulating soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) as diagnostic and prognostic marker in neonatal sepsis. Cytokine. 2014;65:184–91.
45. [45] Arízaga-Ballesteros, V., Alcorta-García, M.R., Lázaro-Martínez, L.C., Amézquita-Gómez, J.M., Alanís-Cajero, J.M., Villela, L., et al. Can sTREM-1 predict septic shock & death in late-onset neonatal sepsis? A pilot study. Int. J. Infect. Dis. 30 (2015), 27–32.
46. [46] Hotoura, E., Giapros, V., Kostoula, A., Spyrou, P., Andronikou, S., Pre-inflammatory mediators and lymphocyte subpopulations in preterm neonates with sepsis. Inflammation 35 (2012), 1094–1101.
47. [47] Ng, P.C., Li, K., Wong, R.P., Chui, K.M., Wong, E., Fok, T.F., Neutrophil CD64 expression: a sensitive diagnostic marker for late-onset nosocomial infection in very low birthweight infants. Pediatr. Res. 51 (2002), 296–303.
48. [48] Clyne, B., Olshaker, J.S., The C-reactive protein. J. Emerg. Med. 17 (1999), 1019–1025.
49. [49] Yang, A.P., Liu, J., Yue, L.H., Wang, H.Q., Yang, W.J., Yang, G.H., Neutrophil CD64 combined with PCT, CRP and WBC improves the sensitivity for the early diagnosis of neonatal sepsis. Clin. Chem. Lab. Med. 54 (2016), 345–351.
50. [50] Ng, P.C., Li, G., Chui, K.M., Chu, W.C., Li, K., Wong, R.P., et al. Neutrophil CD64 is a sensitive diagnostic marker for early-onset neonatal infection. Pediatr. Res. 56 (2004), 796–803.
51. [51] Franz, A.R., Bauer, K., Schalk, A., Garland, S.M., Bowman, E.D., Rex, K., et al. Measurement of interleukin 8 in combination with C-reactive protein reduced unnecessary antibiotic therapy in newborn infants: a multicenter, randomized, controlled trial. Pediatrics 114 (2004), 1–8.
52. [52] Ng, P.C., Biomarkers of necrotising enterocolitis. Semin. Fetal Neonatal Med. 19 (2014), 33–38.
53. [53] Pourcyrous, M., Korones, S.B., Yang, W., Boulden, T.F., Bada, H.S.C., reactive protein in the diagnosis, management, and prognosis of neonatal necrotizing enterocolitis. Pediatrics 116 (2005), 1064–1069.
54. [54] Stocker, M., Hop, W.C., van Rossum, A.M., Neonatal Procalcitonin Intervention Study (NeoPInS): effect of procalcitonin-guided decision making on duration of antibiotic therapy in suspected neonatal early-onset sepsis: a multi-centre randomized superiority and non-inferiority Intervention Study. BMC Pediatr., 10, 2010, 89.
55. [55] Chiesa, C., Natale, F., Pascone, R., Osborn, J.F., Pacifico, L., Bonci, E., et al. C reactive protein and procalcitonin: reference intervals for preterm and term newborns during the early neonatal period. Clin. Chim. Acta 412 (2011), 1053–1059.
56. [56] Altunhan, H., Annagür, A., Örs, R., Mehmetoğlu, I., Procalcitonin measurement at 24 hours of age may be helpful in the prompt diagnosis of early-onset neonatal sepsis. Int. J. Infect. Dis. 15 (2011), e854–e858.
57. [57] Vouloumanou, E.K., Plessa, E., Karageorgopoulos, D.E., Mantadakis, E., Falagas, M.E., Serum procalcitonin as a diagnostic marker for neonatal sepsis: a systematic review and meta-analysis. Intensive Care Med. 37 (2011), 747–762.
58. [58] Yu, Z., Liu, J., Sun, Q., Qiu, Y., Han, S., Guo, X., The accuracy of the procalcitonin test for the diagnosis of neonatal sepsis: a meta-analysis. Scand. J. Infect. Dis. 42 (2010), 723–733.
59. [59] van Rossum, A.M., Wulkan, R.W., Oudesluys-Murphy, A.M., Procalcitonin as an early marker of infection in neonates and children. Lancet Infect. Dis. 4 (2004), 620–630.
60. [60] Kordek, A., Hałasa, M., Podraza, W., Early detection of an early onset infection in the neonate based on measurements of procalcitonin and C-reactive protein concentrations in cord blood. Clin. Chem. Lab. Med. 46 (2008), 1143–1148.
61. [61] Albrich, W.C., Harbarth, S., Pros and cons of using biomarkers versus clinical decisions in start and stop decisions for antibiotics in the critical care setting. Intensive Care Med. 41 (2015), 1739–1751.
62. [62] Cetinkaya, M., Ozkan, H., Köksal, N., Akaci, O., Ozgür, T., Comparison of the efficacy of serum amyloid A, C-reactive protein, and procalcitonin in the diagnosis and follow-up of necrotizing enterocolitis in premature infants. J. Pediatr. Surg. 46 (2011), 1482–1489.
63. [63] Turner, D., Hammerman, C., Rudensky, B., Schlesinger, Y., Wine, E., Muise, A., et al. Low levels of procalcitonin during episodes of necrotizing enterocolitis. Dig. Dis. Sci. 52 (2007), 2972–2976.
64. [64] Arnon, S., Litmanovitz, I., Regev, R., Lis, M., Shainkin-Kestenbaum, R., Dolfin, T., Serum amyloid A protein in the early detection of late-onset bacterial sepsis in preterm infants. J. Perinat. Med. 30 (2002), 329–332.
65. [65] Yuan, H., Huang, J., Lv, B., Yan, W., Hu, G., Wang, J., et al. Diagnosis value of the serum amyloid A test in neonatal sepsis: a meta-analysis. Biomed. Res. Int., 2013 (2013:520294).
66. [66] Ng, P.C., Ang, I.L., Chiu, R.W., Li, K., Lam, H.S., Wong, R.P., et al. Host-response biomarkers for diagnosis of late-onset septicemia and necrotizing enterocolitis in preterm infants. J. Clin. Invest. 120 (2010), 2989–3000.
67. [67] Cetinkaya, M., Ozkan, H., Köksal, N., Akaci, O., Ozgür, T., The efficacy of serial serum amyloid A measurements for diagnosis and follow-up of necrotizing enterocolitis in premature infants. Pediatr. Surg. Int. 26 (2010), 835–841.
68. [68] Peyssonnaux, C., Zinkernagel, A.S., Datta, V., Lauth, X., Johnson, R.S., Nizet, V., TLR4-dependent hepcidin expression by myeloid cells in response to bacterial pathogens. Blood 107 (2006), 3727–3732.
69. [69] TW, W., Tabangin, M., Kusano, R., Ma, Y., Ridsdale, R., Akinbi, H., The utility of serum hepcidin as a biomarker for late-onset neonatal sepsis. J. Pediatr. 162 (2013), 67–71.
70. [70] Cizmeci, M.N., Kara, S., Kanburoglu, M.K., Simavli, S., Duvan, C.I., Tatli, M.M., Detection of cord blood hepcidin levels as a biomarker for early-onset neonatal sepsis. Med. Hypotheses 82 (2014), 310–312.
71. [71] Hilgendorff, A., Windhorst, A., Klein, M., Tchatalbachev, S., Windemuth-Kieselbach, C., Kreuder, J., et al. Gene expression profiling at birth characterizing the preterm infant with early onset infection. J. Mol. Med. (Berl)., 2016.
72. [72] El Gawhary, S., El-Anany, M., Hassan, R., Ali, D., El Gameel eQ. The role of 16S rRNA gene sequencing in confirmation of suspected neonatal sepsis. J. Trop. Pediatr. 62 (2016), 75–80.
73. [73] Liu, D., Du, L., Yu, J., Li, L., Ai, Q., Feng, J., et al. 16S rDNA PCR-DGGE and sequencing in the diagnosis of neonatal late-onset septicemia. Mol. Med. Rep. 12 (2015), 6346–6352.
74. [74] van den Brand, M., Peters, R.P., Catsburg, A., Rubenjan, A., Broeke, F.J., van den Dungen, F.A., et al. Development of a multiplex real-time PCR assay for the rapid diagnosis of neonatal late onset sepsis. J. Microbiol. Methods 106 (2014), 8–15.
75. [75] Kasper, D.C., Altiok, I., Mechtler, T.P., Böhm, J., Straub, J., Langgartner, M., et al. Molecular detection of late-onset neonatal sepsis in premature infants using small blood volumes: proof-of-concept. Neonatology 103 (2013), 268–273.
76. [76] Pammi, M., Flores, A., Leeflang, M., Versalovic, J., Molecular assays in the diagnosis of neonatal sepsis: a systematic review and meta-analysis. Pediatrics 128 (2011), e973–e985.
77. [77] Buhimschi CS, Bhandari V, Hamar BD, Bahtiyar MO, Zhao G, Sfakianaki AK, et al. Proteomic profiling of the amniotic fluid to detect inflammation, infection, and neonatal sepsis. PLoS Med. 2007;4:e18.
78. [78] Buhimschi, I.A., Buhimschi, C.S., The role of proteomics in the diagnosis of chorioamnionitis and early-onset neonatal sepsis. Clin. Perinatol. 37 (2010), 355–374.
79. [79] Buhimschi, C.S., Bhandari, V., Dulay, A.T., Nayeri, U.A., Abdel-Razeq, S.S., Pettker, C.M., et al. Proteomics mapping of cord blood identifies haptoglobin “switch-on” pattern as biomarker of early-onset neonatal sepsis in preterm newborns. PLoS One, 6, 2011, e26111.
80. [80] Mickiewicz, B., Vogel, H.J., Wong, H.R., Winston, B.W., Metabolomics as a novel approach for early diagnosis of pediatric septic shock and its mortality. Am. J. Respir. Crit. Care Med. 187 (2013), 967–976.
81. [81] Fanos, V., Caboni, P., Corsello, G., Stronati, M., Gazzolo, D., Noto, A., et al. Urinary (1)H-NMR and GC-MS metabolomics predicts early and late onset neonatal sepsis. Early Hum. Dev. 90:Suppl. 1 (2014), S78–S83.
82. [82] Perrone, S., Tataranno, M.L., Negro, S., Cornacchione, S., Longini, M., Proietti, F., et al. May oxidative stress biomarkers in cord blood predict the occurrence of necrotizing enterocolitis in preterm infants?. J. Matern. Fetal Neonatal Med. 25:Suppl. 1 (2012), 128–131.
83. [83] Wilcock, A., Begley, P., Stevens, A., Whatmore, A., Victor, S., The metabolomics of necrotising enterocolitis in preterm babies: an exploratory study. J. Matern. Fetal Neonatal Med. 29 (2016), 758–762.
84. [84] Stewart, C.J., Nelson, A., Treumann, A., Skeath, T., Cummings, S.P., Embleton, N.D., et al. Metabolomic and proteomic analysis of serum from preterm infants with necrotising entercolitis and late-onset sepsis. Pediatr. Res. 79 (2016), 425–431.
85. [85] Sullivan, B.A., Fairchild, K.D., Predictive monitoring for sepsis and necrotizing enterocolitis to prevent shock. Semin. Fetal Neonatal Med. 20 (2015), 255–261.
86. [86] Moorman, J.R., Carlo, W.A., Kattwinkel, J., Schelonka, R.L., Porcelli, P.J., Navarrete, C.T., et al. Mortality reduction by heart rate characteristic monitoring in very low birth weight neonates: a randomized trial. J. Pediatr. 159 (2011), 900–906 (e1).
87. [87] Sullivan, B.A., Grice, S.M., Lake, D.E., Moorman, J.R., Fairchild, K.D., Infection and other clinical correlates of abnormal heart rate characteristics in preterm infants. J. Pediatr. 164 (2014), 775–780.
88. [88] Fairchild, K.D., Predictive monitoring for early detection of sepsis in neonatal ICU patients. Curr. Opin. Pediatr. 25 (2013), 172–179.
89. [89] Bhandari, V., Narang, A., Thermoregulatory alterations as a marker for sepsis in normothermic premature neonates. Indian Pediatr. 29 (1992), 571–575.
90. [90] Leante-Castellanos, J.L., Lloreda-García, J.M., García-González, A., Llopis-Baño, C., Fuentes-Gutiérrez, C., Alonso-Gallego, J., et al. Central-peripheral temperature gradient: an early diagnostic sign of late-onset neonatal sepsis in very low birth weight infants. J. Perinat. Med. 40 (2012), 571–576.
91. [91] Ng, E.W., Poon, T.C., Lam, H.S., Cheung, H.M., Ma, T.P., Chan, K.Y., et al. Gut-associated biomarkers L-FABP, I-FABP, and TFF3 and LIT score for diagnosis of surgical necrotizing enterocolitis in preterm infants. Ann. Surg. 258 (2013), 1111–1118.
92. [92] Thuijls, G., Derikx, J.P., van Wijck, K., Zimmermann, L.J., Degraeuwe, P.L., Mulder, T.L., et al. Non-invasive markers for early diagnosis and determination of the severity of necrotizing enterocolitis. Ann. Surg. 251 (2010), 1174–1180.
93. [93] Evennett, N.J., Hall, N.J., Pierro, A., Eaton, S., Urinary intestinal fatty acid-binding protein concentration predicts extent of disease in necrotizing enterocolitis. J. Pediatr. Surg. 45 (2010), 735–740.
94. [94] Mannoia, K., Boskovic, D.S., Slater, L., Plank, M.S., Angeles, D.M., Gollin, G., Necrotizing enterocolitis is associated with neonatal intestinal injury. J. Pediatr. Surg. 46 (2011), 81–85.
95. [95] Terrin, G., Passariello, A., Manguso, F., Salvia, G., Rapacciuolo, L., Messina, F., et al. Serum calprotectin: an antimicrobial peptide as a new marker for the diagnosis of sepsis in very low birth weight newborns. Clin. Dev. Immunol., 2011 (2011:291085).
96. [96] Carroll, D., Corfield, A., Spicer, R., Cairns, P., Faecal calprotectin concentrations and diagnosis of necrotising enterocolitis. Lancet 361 (2003), 310–311.
97. [97] Zhang, M., Zhang, X., Zhang, J., Diagnostic value of fecal calprotectin in preterm infants with necrotizing enterocolitis. Clin. Lab. 62 (2016), 863–869.
98. [98] Nissen, A.C., van Gils, C.E., Menheere, P.P., Van den Neucker, A.M., van der Hoeven, M.A., Forget, P.P., Fecal calprotectin in healthy term and preterm infants. J. Pediatr. Gastroenterol. Nutr. 38 (2004), 107–108.
99. [99] Campeotto, F., Baldassarre, M., Butel, M.J., Viallon, V., Nganzali, F., Soulaines, P., et al. Fecal calprotectin: cutoff values for identifying intestinal distress in preterm infants. J. Pediatr. Gastroenterol. Nutr. 48 (2009), 507–510.
100. [100] Pergialiotis, V., Konstantopoulos, P., Karampetsou, N., Koutaki, D., Gkioka, E., Perrea, D.N., et al. Calprotectin levels in necrotizing enterocolitis: a systematic review of the literature. Inflamm. Res., 2016.
101. [101] Däbritz, J., Jenke, A., Wirth, S., Foell, D., Fecal phagocyte-specific S100A12 for diagnosing necrotizing enterocolitis. J. Pediatr. 161 (2012), 1059–1064.
102. [102] Kopterides, P., Siempos, I.I., Tsangaris, I., Tsantes, A., Armaganidis, A., Procalcitonin-guided algorithms of antibiotic therapy in the intensive care unit: a systematic review and meta-analysis of randomized controlled trials. Crit. Care Med. 38 (2010), 2229–2241.
103. [103] Doheny, K.K., Palmer, C., Browning, K.N., Jairath, P., Liao, D., He, F., et al. Diminished vagal tone is a predictive biomarker of necrotizing enterocolitis-risk in preterm infants. Neurogastroenterol. Motil. 26 (2014), 832–840.